Skip to content

A study to know the effect of two ayurvedic medicines namely dadruhar lepa and raktamokshana (jalaukavcharana)along with Nimba~patola patra kwath in management of dadru w.s.r to tinea

A Randomized Comparative Clinical Study To Evaluate The Efficacy of Dadruhar Lepa and Raktamokshana (Jalaukavcharana) Along With Nimba-Patolapatra Kwath In The Management Of Dadru wsr To Tinea

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041814
Enrollment
60
Registered
2022-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified

Interventions

None listed

Sponsors

Ayurvedic and Unani Tibbia College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing to participate in the trial and sign the consent form. 2. The patients between the age group of 18 to 60 years in either sex. 3. Patients of Dadru with features mentioned in subjective parameters. 4. Patient already taking modern medicine (Antifungals)& Local applications. 5. Patient having Potassium hydroxide (KOH) scrapping test positive

Exclusion criteria

Exclusion criteria: 1. Patients who were not willing for trial or fail to give consent. 2. Patients suffering from any other systemic illness,liver disorder, tuberculosis,bleeding disorder etc. 3. Pregnant and lactating women. 4. Patients taking antibiotic therapy for any systemic illness within 2 months. 5. H/O of hypersensitivity of any trial drug. 6. Allergic reaction to active substances of the leech such as hirudin,calin,hyaluronidase,egline,kollagenage,apyrase,destabilase,piyavit etc. 7. Patients with genetic and endocrinal disorder, chronic disorder like paralysis, cancer, renal failure, hepatic failure and IHD. 8. Patients having Tinea manuum and Tinea unguim. 9. Raktamokshana (jalaukavcharana)will not be done in Patients having diabetes mellitus.

Design outcomes

Primary

MeasureTime frame
Improvement in subjective parameters. Raga (Inflammation) Pidika (Eruption) Daha (Burning sensation) Rookshata (Dryness) Udgata mandal (Elevated lesion)Timepoint: 12 weeks

Secondary

MeasureTime frame
Assessment will be done clinically on basis of decrease in subjective parameters of dadruTimepoint: 12 weeks

Countries

India

Contacts

Public ContactDr Sujata Yadav

Ayurvedic and Unani Tibbia college and hospital karol bagh New Delhi

sujatakcdelhi@gmail.com9810571653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026